Meme coin GIGGLE's market cap surges 10% in a short time, currently reported at $27.5 million

October 5 – Vaxcyte (PCVX.O) shares surged 26% pre-market to $71.17. Vaxcyte announced that its 31-valent pneumococcal vaccine VAX-31 met all primary endpoints in a late-stage clinical trial, and generated immune responses comparable to or stronger than Pfizer’s Prevnar 20 and Merck’s Capvaxive. The safety and tolerability of the vaccine were similar to existing vaccines. Vaxcyte expects results from two additional late-stage clinical trials in the first half of 2027, and plans to submit a marketing application to the FDA in the first half of 2028. As of the previous trading session’s close, the stock had risen 22.4% year-to-date.

Linde will publish third-quarter 2026 results on Oct. 29, 2026 by 6:00 a.m. EDT (11:00 a.m. CET). Conference call webcast set for Oct. 29, 2026 at 9:00 a.m. EDT (2:00 p.m. CET). Web replay available from Oct. 29, 2026 at 10:30 a.m. EDT (3:30 p.m. CET) via https://www.linde.com/investors/financial-reports. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Linde plc published the original content used to generate this news brief via EQS News (Ref. ID: corporate_2409690_en) on October 05, 2026, and is solely responsible for the information contained therein.

On October 5th, shares of software company PTC (PTC.O) surged by 34.6% in pre-market trading to $193.8 after France's Schneider Electric (SCHN.PA) agreed to acquire PTC in an all-cash deal valuing PTC's equity at approximately $22.6 billion. The offer price of $205 per share represents an enterprise value of $23.7 billion, a 42.3% premium over PTC’s previous closing price. According to data from London Stock Exchange Group (LSEG), this is the largest acquisition in Schneider Electric’s history. Following the agreement to acquire private AI software and industrial data provider Cognite Holding in June this year, this deal marks another significant step in SCHN’s expansion into the software sector. As of the previous day’s close, PTC shares were down 17.3% year-to-date, while SCHN’s shares had risen 17.4% for the year.